TMCnet News

Research and Markets: Scar Pipeline Review, H1 2015 - 20 Companies & 27 Companies
[June 11, 2015]

Research and Markets: Scar Pipeline Review, H1 2015 - 20 Companies & 27 Companies


Research and Markets (http://www.researchandmarkets.com/research/q5b3gf/scar_pipeline) has announced the addition of the "Scar - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Scar, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Scar and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Terapeutics Development



  • 3M (News - Alert) Drug Delivery Systems
  • AlbireoPharma
  • Altacor Ltd.
  • Amakem NV
  • Beech Tree Labs, Inc.
  • Biomolecular Therapeutics GmbH
  • BiOrion Technologies B.V.
  • Clanotech AB
  • Critical Outcome Technologies Inc.
  • Derma Sciences, Inc.
  • Easton Pharmaceuticals Inc.
  • Escape Therapeutics, Inc.
  • EyeGene, Inc.
  • Fibrocell Science, Inc.
  • FirstString Research, Inc.
  • Juventas Therapeutics, Inc.
  • Kasiak Research Pvt. Ltd.
  • Pergamum AB
  • RXi Pharmaceuticals Corporation
  • Symic Biomedical, Inc.

Drug Profiles

  • A-3914
  • A-5425
  • AMA-0526
  • azficel-T
  • BMT-101
  • BOT-191
  • BTL-slo
  • CLT-28643
  • CM-101
  • decorin
  • Drug to Agonize Beta 2 Receptor for Wound Scars
  • DSC-127
  • EGS-001
  • EP-003
  • FibroStem
  • Granexin
  • ICX (News - Alert)-RHY
  • JVS-100
  • nefopam hydrochloride
  • PXL-01
  • Refaglo
  • RXI-109
  • S-34240
  • Small Molecules for Wounds and Scars
  • Small Molecules to Activate SOX-9 for Scar
  • Synthetic Peptides to Antagonize TGF-Beta Receptor for Diabetic Foot Ulcers, Pulmonary Fibrosis and Dermatology
  • tranilast

For more information visit http://www.researchandmarkets.com/research/q5b3gf/scar_pipeline



[ Back To TMCnet.com's Homepage ]